The most recent addition to our treatment armamentarium for presbyopia is the use of pharmaceutical agents that induce pupil miosis which results in an extended depth of focus to improve near vision. Contact lenses have been a mainstay in presbyopia management. This course will explore how new pharmaceutical options can optimize outcomes in the treatment of presbyopia when used in combination with a variety of contact lens modalities.
Over 900 attended our event and we received amazing feedback!
Feedback from anonymous survey:
So clear/to the point and thought provoking! I really enjoyed this CE
Great range of topic details, Dr Eiden is very easy to listen to!
Love the new approaches!
This is one of the top lectures, so informative and practical! Thoroughly enjoyed this CE!
Interesting topic re: CL wear combined with presbyopic drops. Great ideas!
Great topic by a great speaker - loved the quotes and experiences from other eyecare professionals, too.
Very good presentation with concise notes.
Good to hear about other OD experiences.
Very good increased presbyopia option presentation.
Speaker: Barry Eiden, O.D.
Moderator: Dr. Jennifer Stewart
COPE ID: 102731-PH
Category: Pharmacology
Thank you to Lenz Therapeutics for exhibiting at this event.
This event is COPE approved for 1 hour of Pharmacology CE credit.